Cannabidiol in Parkinson's disease

Braz J Psychiatry. 2020 Apr;42(2):126-127. doi: 10.1590/1516-4446-2019-0810. Epub 2020 Mar 16.
No abstract available

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Cannabidiol / therapeutic use*
  • Humans
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Cannabidiol